Published in Crit Care Med on December 01, 1986
Ethical and practical considerations in providing critical care to patients with Ebola virus disease. Chest (2015) 2.05
Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med (2013) 1.71
Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax (2006) 1.35
Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax (2007) 1.30
Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr (2013) 1.23
Critical illness in HIV-infected patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 0.92
Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Thorax (1990) 0.81
Intensive care for advanced HIV disease. Genitourin Med (1992) 0.81
The effect of human immunodeficiency virus infection on the distribution and outcome of pneumonia in intensive care units. West J Med (1992) 0.81
Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICU. Eur J Clin Microbiol Infect Dis (2013) 0.79
Clinical review: Respiratory failure in HIV-infected patients--a changing picture. Crit Care (2013) 0.78
AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome. Thorax (1990) 0.76
Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy. Can J Infect Dis Med Microbiol (2017) 0.75
HIV Infection and Severe Sepsis: A Bitter Pill to Swallow. Crit Care Med (2015) 0.75
Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome. J Crit Care (2014) 0.75
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA (1992) 7.84
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25
A look into the nature and causes of human errors in the intensive care unit. Crit Care Med (1995) 5.14
Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35
Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA (1987) 3.99
Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med (1998) 3.64
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet (1988) 3.37
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25
Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med (1995) 3.19
Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA (1997) 3.11
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis (1985) 2.76
Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med (1995) 2.66
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med (1983) 2.45
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37
Plasma cortisol levels in patients with septic shock. Crit Care Med (1990) 2.33
High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. Lancet (1987) 2.30
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study. Ann Intern Med (1992) 2.19
Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine. Crit Care Med (1998) 2.14
Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol (1998) 2.12
Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis. Clin Infect Dis (2000) 2.08
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med (1997) 2.06
Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis (1994) 2.06
Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA (1985) 2.02
Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997. Chest (2001) 1.91
Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med (1998) 1.85
Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 1.84
Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.80
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis (1992) 1.73
The prevalence of tuberculosis and drug resistance among Haitians. N Engl J Med (1982) 1.68
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA (1991) 1.62
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med (1993) 1.62
Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med (1989) 1.62
Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med (1990) 1.61
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol (1993) 1.61
Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study. Am Rev Respir Dis (1987) 1.59
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med (1992) 1.53
The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53
Living related donation in lung transplantation. Ethical considerations. Arch Intern Med (1995) 1.53
Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51
Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol (1987) 1.51
Why have new effective therapies for sepsis not been developed? Crit Care Med (1994) 1.50
CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. AIDS (1998) 1.49
An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med (1981) 1.45
Fulminant hepatic failure from a sea anemone sting. Ann Intern Med (1994) 1.43
Prior healthcare utilization as a predictor of survival for medical intensive care unit patients. Crit Care Med (2000) 1.42
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). Antimicrob Agents Chemother (2000) 1.42
Blast lung injury from an explosion on a civilian bus. Chest (1999) 1.42
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med (1993) 1.42
HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med (1994) 1.40
Acquired immunodeficiency syndrome and critical care. Crit Care Med (1990) 1.39
Definition of sepsis. Intensive Care Med (2001) 1.34
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Antimicrob Agents Chemother (1999) 1.32
A look into the nature and causes of human errors in the intensive care unit. 1995. Qual Saf Health Care (2003) 1.31
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.28
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis (1996) 1.21
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis (1998) 1.20
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med (2001) 1.18
Kaposi's sarcoma of the tracheobronchial tree. Clinical, bronchoscopic, and pathologic features. Chest (1985) 1.18
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med (1993) 1.11
Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome. Arch Intern Med (1986) 1.11
Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr (1993) 1.10
Holy consent--a dilemma for medical staff when maternal consent is withheld for emergency caesarean section. Int J Obstet Anesth (2006) 1.07
Tuberculous brain abscess and Toxoplasma encephalitis in a patient with the acquired immunodeficiency syndrome. JAMA (1985) 1.06
Enteric coccidiosis among patients with the acquired immunodeficiency syndrome. Am J Trop Med Hyg (1984) 1.06
Hemodynamic alterations of heat stroke in the elderly. Chest (1979) 1.03
Evidence for increased permeability in reexpansion pulmonary edema. Am J Med (1981) 1.03
Is the physician's duty to the individual patient or to society? Crit Care Med (1995) 1.02
The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study. J Med Ethics (2006) 1.02
Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest (1981) 1.01
The acquired immunodeficiency syndrome in the wife of a hemophiliac. Ann Intern Med (1984) 1.01
Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med (1999) 0.99